Biological action of nitric oxide donor compounds on platelets from patients with sickle cell disease
Traci Heath Mondoro
Laboratory of Cellular Hematology and Laboratory of Plasma Derivatives, Center for Biologics Evaluation and Research, Food and Drugs Administration, and
Search for more papers by this authorBeth Brockner Ryan
Laboratory of Cellular Hematology and Laboratory of Plasma Derivatives, Center for Biologics Evaluation and Research, Food and Drugs Administration, and
Search for more papers by this authorBorys W. Hrinczenko
Laboratory of Chemical Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA
Search for more papers by this authorAlan N. Schechter
Laboratory of Chemical Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA
Search for more papers by this authorJaroslav G. Vostal
Laboratory of Cellular Hematology and Laboratory of Plasma Derivatives, Center for Biologics Evaluation and Research, Food and Drugs Administration, and
Search for more papers by this authorAbdu I. Alayash
Laboratory of Cellular Hematology and Laboratory of Plasma Derivatives, Center for Biologics Evaluation and Research, Food and Drugs Administration, and
Search for more papers by this authorTraci Heath Mondoro
Laboratory of Cellular Hematology and Laboratory of Plasma Derivatives, Center for Biologics Evaluation and Research, Food and Drugs Administration, and
Search for more papers by this authorBeth Brockner Ryan
Laboratory of Cellular Hematology and Laboratory of Plasma Derivatives, Center for Biologics Evaluation and Research, Food and Drugs Administration, and
Search for more papers by this authorBorys W. Hrinczenko
Laboratory of Chemical Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA
Search for more papers by this authorAlan N. Schechter
Laboratory of Chemical Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA
Search for more papers by this authorJaroslav G. Vostal
Laboratory of Cellular Hematology and Laboratory of Plasma Derivatives, Center for Biologics Evaluation and Research, Food and Drugs Administration, and
Search for more papers by this authorAbdu I. Alayash
Laboratory of Cellular Hematology and Laboratory of Plasma Derivatives, Center for Biologics Evaluation and Research, Food and Drugs Administration, and
Search for more papers by this authorAbstract
Several lines of evidence point to the potential role of nitric oxide (NO) in the pathophysiology, as well as in the therapy, of sickle cell disease (SCD). In this study, we compared the effects of NO on platelets from normal individuals and from patients with SCD. Three NO donors were used to deliver NO to platelets: sodium 2-(N, N-diethylamino)-diazenolate-2-oxide (DEANO), S-nitrosocysteine (CysNO) and sodium trioxdintrate (OXINO or Angeli's salt). ADP-induced platelet aggregation, CD62P expression, PAC-1 binding and calcium elevation were evaluated in paired studies of normal and SCD subjects. DEANO significantly reduced aggregation in SCD platelets compared with normal platelets. DEANO similarly reduced the extent of CD62P expression in SCD platelets. All NO donors reduced PAC-1 binding, but there were no significant differences between platelets from normal or SCD subjects. Calcium elevation, as induced by ADP, was not altered by the presence of NO donors. However, when platelets were stimulated with thrombin, there was an increased initial response of SCD platelets compared with normal platelets. Taken together, these data suggest that the mode of NO delivery to platelets may produce various physiological responses and the optimization of NO delivery may contribute to reducing platelet aggregation in sickle cell disease.
References
- Allan, D., Limbrick, A., Thomas, P., Westerman, M. (1981) Microvesicles from sickle erythrocytes and their relation to irreversible sickling. British Journal of Haematology, 47, 383–390.
- Beurling-Harbury, C. & Schade, S. (1989) Platelet activation during crisis in sickle cell anemia patients. American Journal of Hematology, 31, 237–241.
- Brittain, H., Eckman, J., Swerlick, R., Howard, R., Wick, T. (1993) Thrombospondin from activated platelets promotes sickle cell erythrocyte adherence to human microvascular endothelium under physiologic flow: a potential role for platelet activation in sickle cell vaso-occlusion. Blood, 81, 2137–2143.
- Browne, P., Mosher, D., Steinberg, M., Hebbel, R. (1996) Disturbance of plasma and platelet thrombospondin levels in sickle cell disease. American Journal of Hematology, 51, 296–301.DOI: 10.1002/(sici)1096-8652(199604)51:4<296::aid-ajh8>3.0.co;2-r
- Feelisch, M. & Stamler, J. (1996) Donors of nitrogen oxides. In: Methods in Nitric Oxide Research (ed. by M. Feelisch & J. Stamler), pp. 5–115. John Wiley and Sons, New York.
- Ferranti, P., Malorni, A., Mamone, G., Sannolo, N., Marino, G. (1997) Characterisation of S-nitrosohaemoglobin by mass spectrometry. FEBS Letters, 400, 19–24.DOI: 10.1016/s0014-5793(96)01258-6
- Fukuto, J., Chiang, K., Hszieh, R., Wong, P., Chaudhuri, G. (1992) The pharmacological activity of nitroxyl: a potent vasodilator with activity similar to nitric oxide and/or endothelium-derived relaxing factor. Journal of Pharmacology and Experimental Therapeutics, 263, 546–551.
- Gladwin, M., Schechter, A., Shelhamer, J., Pannel, L., Conway, D., Hrinczenko, B., Nichols, J., Pease-Fye, M., Noguchi, C., Rodgers, G., Ognibene, F. (1999) Inhaled nitric oxide augments nitric oxide transport on sickle cell hemoglobin without affecting oxygen affinity. Journal of Clinical Investigation, 104, 937–945.
- Head, C., Brugnara, C., Martinez-Ruiz, R., Kacmarek, R., Bridges, K., Kuter, D., Block, K., Zapol, W. (1997) Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo. Journal of Clinical Investigation, 100, 1193–1198.
- Hrinczenko, B., Alayash, A., Wink, D., Gladwin, M., Rodgers, G., Schechter, A. (2000a) Effect of nitric oxide and nitric oxide donors on red blood cell oxygen transport. British Journal of Haematology, 110, 1–9.DOI: 10.1046/j.1365-2141.2000.02272.x
- Hrinczenko, B., Schechter, A., Wojtkowski, T., Pannell, L., Cashon, R., Alayash, A. (2000b) Nitric oxide-mediated heme oxidation and selective beta-globin nitrosation of hemoglobin from normal and sickle erythrocytes. Biochemical Biophysical Research Communications, 275, 962–967.
- Ignarro, L., Lippton, H., Edwards, J., Baricos, W., Hyman, A., Kadowitz, P., Gruetter, C. (1981) Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. Journal of Pharmacology and Experimental Therapeutics, 218, 739–749.
- Keh, D., Gerlach, M., Kurer, I., Seiler, S., Kerner, T., Falke, K., Gerlach, H. (1996) The effects of nitirc oxide (NO) on platelet membrane receptor expression during activation with human alpha-thrombin. Blood Coagulation and Fibrinolysis, 7, 615–624.
- Kon, K., Maeda, N., Shiga, T. (1977) Effect of nitric oxide on the oxygen transport of human erythrocytes. Journal of Toxicology in Environmental Health, 2, 1109–1113.
- Kuranstin-Mills, J., Ibe, B., Raj, J., Siegel, R., Lessin, L. (1994) Elevated urinary levels of thromboxane and prostacyclin metabolites in sickle cell disease reflects activated platelets in the circulation. British Journal of Haematology, 87, 580–585.
- Kuypers, F., Van Den Berg, J., Lubin, B. (1994) Membrane lipids and vesiculation. In: Sickle Cell Disease: Basic Principles and Clinical Practice (ed. by S. Embury, R. Hebbel, N. Nohandas & M. Steinberg), pp. 139–150. Raven Press, New York.
- Lopez, B., Barnett, J., Ballas, S., Christopher, T., Davis-Moon, L., Ma, X. (1996) Nitric oxide metabolite levels in acute vaso-occlusive sickel cell crisis. Academic Emergency Medicine, 3, 1098–1103.
- Mehta, P. & Mehta, J. (1980) Abnormalities of platelet aggregation in sickle cell disease. Journal of Pediatrics, 96, 209–213.
- Morley, D., Maragos, C., Zhang, X.-Y., Boignon, M., Wink, D., Keefer, L. (1993) Mechanism of vascular relaxation induced by the nitric oxide (NO)/nucleophile complexes, a new class of NO-based vasodilators. Journal of Cardiovascular Pharmacology, 21, 670–676.
- Phillips, D., Charo, I., Parise, L., Fitzgerald, L. (1988) The platelet membrane glycoprotein IIb-IIIa complex. Blood, 71, 831–842.
- Pino, R. & Feelisch, M. (1994) Bioassay discrimination between nitric oxide (NO.) and nitroxyl (NO-) using l-cysteine. Biochemical Biophysical Research Communications, 201, 54–62.
- Radomski, M., Palmer, R., Moncada, S. (1987) Comparative pharmacology of endothelial-derived relacing factor, nitric oxide and prostacyclin in platelets. British Journal of Pharmacology, 92, 181–187.
- Rees, D., Cervi, P., Grimwade, D., O'Driscoll, A., Hamilton, M., Parker, N., Porter, J. (1995) The metabolites of nitric oxide in sickle cell disease. British Journal of Haematology, 91, 834–837.
- Rink, T. & Sage, S. (1990) Calcium signaling in human platelets. Annual Review of Physiology, 52, 431–449.
- Samama, C., Diaby, M., Fellahi, J., Mdhafar, A., Eryaud, D., Arock, M., Guillosson, J., Coriat, P., Rouby, J. (1995) Inhibition of platelet aggregation by inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesthesiology, 83, 56–65.
- Shattil, S.J., Hoxie, J.A., Cunningham, M., Brass, L.F. (1985) Changes in the platelet membrane glycoprotein IIb-IIIa complex during activation. Journal of Biological Chemistry, 260, 11107–11114.
- Shattil, S., Cunningham, M., Hoxie, J. (1987) Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood, 70, 307–315.
-
Space, S.,
Lane, P.,
Pickett, C.,
Weil, J. (2000) Nitric oxide attenuates normal and sickle red blood cell adherenece to pulmonary endothelium.
American Journal of Hematology, 63, 200–204.DOI: 10.1002/(sici)1096-8652(200004)63:4<200::aid-ajh7>3.0.co;2-q
10.1002/(sici)1096-8652(200004)63:4<200::aid-ajh7>3.0.co;2-q CAS PubMed Web of Science® Google Scholar
- Stamler, J. (1995) S-nitrosothiols and the bioregulatory actions of nitrogen oxides through reactions with thiol groups. Current Topics in Microbiology and Immunology, 196, 19–36.
- Vanderford, P., Wong, J., Chang, R., Keefer, L., Soifer, S., Fineman, J. (1994) Diethylamine/nitric oxide (NO) adduct, an NO donor, produces potent pulmonary and systemic vasodilation in intact newborn lambs. Journal of Cardiovascular Pharmacology, 23, 113–119.
- Wun, T., Paglieroni, T., Rangaswami, A., Franklin, P., Welborn, J., Cheung, A., Tablin, F. (1998) Platelet activation in patients with sickle cell disease. British Journal of Haematology, 100, 741–749.DOI: 10.1046/j.1365-2141.1998.00627.x
Citing Literature
